Jane Street Group, LLC Tenaya Therapeutics, Inc. Transaction History
Jane Street Group, LLC
- $616 Billion
- Q3 2025
A detailed history of Jane Street Group, LLC transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 156,255 shares of TNYA stock, worth $212,506. This represents 0.0% of its overall portfolio holdings.
Number of Shares
156,255
Previous 376,068
58.45%
Holding current value
$212,506
Previous $229,000
4.37%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding TNYA
# of Institutions
97Shares Held
38.2MCall Options Held
313KPut Options Held
61.1K-
Column Group LLC San Francisco, CA9.4MShares$12.8 Million18.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.06MShares$6.89 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.5MShares$6.13 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$5.54 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.68MShares$2.28 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $56.3M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...